3 Best Performing ASX shares in week 48, 6 December 2021
Marc Kennis, December 13, 2021
Best performing ASX shares: Two of the three best performing ASX stocks are (ex) Marc & Stuart’s Top Picks: Neuren Pharmaceuticals (ASX:NEU) was up 117.5% and Revasum (ASX:RVS) went up 39.8%. Sky Network Television (ASX:SKT) rose 36.5% last week and completed the Top 3 Best performing ASX shares.
1. Neuren Pharmaceuticals (ASX: NEU)
Industry: Healthcare
Neuren Pharmaceuticals (ASX: NEU) is an ex-Top Pick on which we made more than 78% earlier this year. It is a biopharmaceutical company developing therapies for brain injury, neurodevelopmental and neurodegenerative disorders. It has two key drug products comprising NNZ-2566 and NNZ-2591 and has operations in New Zealand, Australia and the USA.
Market Cap: $485M
12 month high / low: $4.04 – $1.20
2. Revasum (ASX:RVS)
Industry: Technology
Revasum (ASX:RVS) is a current Top Pick. The company specialises in the design and manufacturing of equipment used to build semiconductors, specifically grinders and polishers for Silicon Carbide (SiC) wafers. SiC chips are used in high voltage applications, like Electric Vehicles and Solar. Revasum’s technology and equipment assists in the advancement of technology for a range of markets and applications including automotive, IoT, 5G, telecommunications, electrification and power devices.
Market Cap: $76M
12 month high / low: $0.88 – $0.21
3. Sky Network Television (ASX:SKT)
Industry: Consumer
Sky Network Television (ASX:SKT) is a New Zealand broadcasting company that provides pay television services via satellite, media streaming services and broadband internet services. It is also a wholesale channel provider to New Zealand IPTV provider Vodafone.
Market Cap: $405M
12 month high / low: $2.32 – $1.40
Learn more about ASX-listed stocks with
Stocks Down Under!
Subscribe to Stocks Down Under today!
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Analysts aren’t optimistic about iron ore prices in 2025, will they be right and what will it mean for iron ore stocks?
In which direction will iron ore prices in 2025 go? Chinese trade data would suggest upwards, and indeed prices jumped…
Paradigm Biopharmaceuticals’ flagship drug Zilosul will be in Phase 3 in 2025
Paradigm Biopharmaceuticals (ASX:PAR) has been listed for nearly a decade with the goal of bringing its flagship drug pentosan polysulfate…
Findi (ASX:FND): Its quadrupled in 12 months off the back of financial services in India
Until Findi (ASX:FND) came along, there were practically no ASX companies making money from India (or at least not many…